Extracorporeal life support as a bridge to high-urgency heart transplantation

Clin Transplant. 2012 May-Jun;26(3):484-8. doi: 10.1111/j.1399-0012.2011.01525.x. Epub 2011 Sep 15.

Abstract

Extracorporeal life support (ECLS) represents an effective, emergent therapy for patients with end-stage heart failure or cardiac arrest. However, ECLS is typically not used as a bridge to heart transplantation because of the limited duration of ECLS. In France, high-urgency priority heart transplantation remains a possibility for transplant patients who are on ECLS. In this article, we present our experience with high-urgency priority heart transplantation after ECLS. From July 2004 to December 2009, 242 patients underwent emergent ECLS. Heart transplantation was performed in eight of these patients. Time of ECLS was 6.3 ± 4.6 d. Before heart transplantation, all patients on ECLS had decreased organ dysfunctions and four were conscious. Despite frequent post-operative complications, no death occurred during the first year after transplantation. In our experience, ECLS is a valid method of supporting patients awaiting high-urgency heart transplantation and can be used as a short-term bridge to heart transplantation.

MeSH terms

  • Adult
  • Extracorporeal Circulation
  • Extracorporeal Membrane Oxygenation*
  • Follow-Up Studies
  • France
  • Heart Failure / mortality*
  • Heart Failure / therapy*
  • Heart Transplantation*
  • Heart-Assist Devices*
  • Humans
  • Life Support Systems*
  • Male
  • Middle Aged
  • Preoperative Care
  • Prognosis
  • Shock, Cardiogenic / mortality
  • Shock, Cardiogenic / therapy*
  • Survival Rate
  • Time Factors
  • Young Adult